4//SEC Filing
DARGAN CHARLES K 4
Accession 0001437749-21-013197
CIK 0000880242other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 8:19 PM ET
Size
19.6 KB
Accession
0001437749-21-013197
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2021-03-18+300,000→ 3,626,500 totalExercise: $0.17From: 2021-03-18Exp: 2031-03-18→ Common stock (300,000 underlying) - Award
Option to purchase common stock
2021-05-21+30,000→ 3,659,000 totalExercise: $0.18From: 2021-05-21Exp: 2031-05-21→ Common stock (30,000 underlying) - Award
Option to purchase common stock
2021-05-21+2,500→ 3,629,000 totalExercise: $0.18From: 2021-05-21Exp: 2031-05-21→ Common stock (2,500 underlying)
Footnotes (5)
- [F1]This amount reflects, in addition to the reported option grant, the expiration, during the first quarter of 2021, of options to purchase an an aggregate 130,000 shares of common stock.
- [F2]The Option is exercisable according to its vesting schedule: (i) 25,000 shares vested as of March 18, 2021, and then (ii) in equal monthly installments of 25,000 shares beginning April 18, 2021, so long as the Engagement Extension Agreement dated March 18, 2021, between Reporting Owner and Issuer, remains in force and effect.
- [F3]This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from January 31, 2021, through January 31, 2022.
- [F4]This Option was granted to Reporting Person to replace an option to purchase 10,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
- [F5]This Option was granted to Reporting Person to replace an option to purchase 120,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
Documents
Issuer
BIOLARGO, INC.
CIK 0000880242
Entity typeother
Related Parties
1- filerCIK 0001112799
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 8:19 PM ET
- Size
- 19.6 KB